Investigational Drug Details
| Drug ID: | D507 |
| Drug Name: | Ebastine |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB11742 |
| DrugBank Description: | Ebastine is under investigation for the treatment of Irritable Bowel Syndrome (IBS). Ebastine has been investigated for the treatment of Urticaria. |
| PubChem ID: | 3191 |
| CasNo: | 90729-43-4 |
| Repositioning for NAFLD: | Yes |
| SMILES: | CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1 |
| Structure: |
|
| InChiKey: | MJJALKDDGIKVBE-UHFFFAOYSA-N |
| Molecular Weight: | 469.6576 |
| DrugBank Targets: | |
| DrugBank MoA: | |
| DrugBank Pharmacology: | |
| DrugBank Indication: | |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|